MannKind strikes deal for inhalable hypertension treatment, sending stock soaring

Southern California drugmaker MannKind Corp. has struck a deal with biotechnology firm United Therapeutics Corp., to collaborate on an inhalable drug to treat a type of hypertension. The agreement, announced Tuesday, provides MannKind with an upfront payment of $45 million and the potential for...